Dear Team,

I am pleased to inform you that earlier this week, Pratia signed an agreement to acquire a majority stake in the Turkish SMO “Atlas” headquartered in Istanbul. This transaction represents the first step in Pratia’s broader expansion strategy in this geography.

About Atlas

Atlas’s core business is the provision of site services, specifically the outsourcing of trained clinical trial coordinators (currently over 240) to research sites across Turkey. Its key customers include AstraZeneca, Novo Nordisk, and MSD.

Why Turkey

We view Turkey as a high-potential emerging market for clinical research, with investment levels exceeding USD 520 million in 2024 (representing 69% year-on-year growth).

The country combines a large population of more than 85 million with a relatively low number of active clinical studies across Turkey as a whole (886 active studies in 2025), compared to leading EU markets, creating strong growth potential.

What this means for Pratia

The investment in Atlas marks Pratia’s and the Humaneva Group’s entry into the Turkish market. Together with our local team, we plan to develop an embedded research site business line in cooperation with local healthcare providers on top of existing Site Service Provision. Further updates on our development in Turkey will follow in due course.

Acknowledgements

I would like to take this opportunity to thank all teams who supported this lengthy and complex due diligence and negotiation process, including in particular the Legal team (Anna Averitt, Paz Guillen), Finance (Jakub Grabowski), M&A (Patrycja Król), Portfolio Management (Chloe Rose, Maciej Zawadzki), Digital Start-Up (Paweł Szcześniak), Quality (Joanna Job), HR (Mateusz Rybicki), and IT (Ramanan Bathala).

Welcome to an overview of the strategic leadership evolution that supports Humaneva Group’s continued global expansion and further strengthens its integrated clinical research operations:

Effective immediately, Łukasz Bęczkowski, who has served as Pratia’s Chief Operating Officer for the past five years, assumes the role of Global Chief Executive Officer.

Łukasz brings a deep operational understanding of the organization, a strong leadership track record, and a clear vision for guiding Pratia through its next stage of innovation and international expansion. In his new role, Łukasz will focus on accelerating international growth, advancing operational excellence, and strengthening partnerships with Sponsors and CROs across multiple therapeutic areas.

As part of this transition, Tomek Dąbrowski, co-founder and Chief Executive Officer of Pratia for over twelve years, moves into the role of Executive Chair of Pratia. He will continue to serve as HUMANEVA Group CEO.

Tomek will focus on scaling the Group’s 2,000-strong organization across four continents and twelve countries, strengthening a unified corporate culture, and driving strategy execution across all business lines.

To support Pratia’s continued growth, and ensure strong operational leadership, the company has appointed Tomasz Groń as Vice President Operations Europe, reporting directly to Łukasz Bęczkowski.

In his role, Tomasz oversees operations across seven European countries, with all Country Heads reporting to him effective immediately, and focuses on strengthening execution, scalability, and consistency across Pratia’s European Research Sites. He brings over 20 years of experience in large, multi-country organisations, with proven success in scaling operations, expanding multi-site networks, and introducing data-driven and omnichannel initiatives that support sustainable growth.

Dannelle is a co-founder of OncoBay, who as COO of Kapadi led the integration of our 5 CRO entities and ensured consistent quality delivery for our CRO customers. She has also played a critical role in developing Pop-up Sites, an initiative that will play a pivotal role in our drive towards uniting the clinical research ecosystem.

In this new role, Dannelle will drive cross-company alignment with our vision: to unite the clinical research ecosystem to improve the life of every cancer patient. She will focus on building an aligned group with shared Culture, Strategy, and Operating Model. Operational Excellence (led by Magda Gisman) and Corporate Strategy (led by Basia Walensa) teams now report directly to Dannelle.

Bartek has an extensive experience with Neuca and the NEKK marketing agency, where he led numerous strategic initiatives - including the NEUCA LinkedIn communication strategy. More recently, Bartek has supported us on key projects such as the brand merger of OncoBay and Clinscience with Agati, patient engagement campaigns, and the creation of the Humaneva brand. Bartek is a hands-on, tech-savvy marketing leader and a strategic thinker.

Piotr brings over 15 years of progressive experience in driving large-scale IT transformations, fostering engineering excellence, and delivering significant business value through strategic technology modernization, user-centric product development, and innovation. Piotr reports directly to Ramanan Bathala.

In this role, Piotr will be accountable for driving Humaneva Technology Strategy, R&D, and Innovation roadmap, strengthening Humaneva technology platforms and engineering practices across Hyggio.

Piotr's operational perspective will complement our existing technology leadership, allowing us to better balance our focus between delivering excellence in current operations and nurturing the innovations that will define our technology future.

Robert Mitraszewski will lead the R&D, Technology Innovation and reports directly to Piotr. The transition of responsibilities will allow Along with Robert to focus solely on strategic Hyggio R&D initiatives, starting February, 2026. All current functional leads: Mateusz Czarnecki, Denis Wrobel, Ramprasad R and Premkumar U P will also directly report to Piotr.

IT Operations will be led by Juan Rodriguez under Ramanan Bathala.

The Annual Performance Appraisal cycle is now active. They are an important opportunity to pause, reflect, and have meaningful conversations about accomplishments, growth, and what comes next. Please follow the steps below to complete your part of the process.

Accessing Your Appraisal Form

Your appraisal form is available in NEUCAnet → “My Employee Appraisals”

Steps You Must Complete

1. Self‑Assessment (Due 30 January)

2. Manager’s Assessment

After you submit your self‑assessment, your manager will complete their evaluation.

3. One‑to‑One Development Meeting (By 28 February)

Your manager will schedule a meeting to discuss your performance, development, and next steps.

4. Final Review and Sign‑Off

After the meeting, you will review the final form and sign it to complete the process.

This Year’s Rating Structure

80% – Task Completion / Goals Achievement

20% – Knowledge and Skills

0% – Values (feedback only)

We hope you find these next few weeks to be insightful and productive. If you need support, contact your manager or local HR.

This growth reinforces our position in oncology research both in Poland and globally — making the Katowice site an increasingly strategic partner for Sponsors seeking high-quality, efficiently executed trials.
Since its opening in 2020, the site has already conducted over 100 international clinical trials, offering patients access to advanced diagnostics and innovative treatments including immunologic therapies in hematologic and solid tumour indications.
Faster access to therapies, improved infrastructure and enhanced patient experience mean we’re better positioned to enroll, execute and deliver results — while maintaining our high standards of care and operational excellence.

Looking ahead

Our team in Katowice remains committed to delivering hope, innovation and access to patients living with cancer — and this expansion allows us to do so at a scale matching our ambition. As we continue to expand trial opportunities and partnerships, your role in enabling this — through your expertise, collaboration and commitment to excellence — is more important than ever.

Let’s continue to seize the momentum together. Thank you for your ongoing dedication and professionalism.

Hi Everyone,

As part of our ongoing efforts to strengthen collaboration and alignment across the Humaneva Group, we have developed a new, dedicated HR structure. We’ve reimagined how HR should be organized at a Group level to answer the needs of our employees. The new structure centralizes HR expertise, promoting a streamlined and unified approach while allowing for a more collaborative, regional focus. The transformation of our HR organization reaches across the Humaneva Group. The change we’re introducing is also the result of valuable feedback from many of you, as well as the foundational work of earlier initiatives.

What’s changing?

I'm happy to announce the promotions of three leaders who will play a key role in shaping the future of HR across the Humaneva Group:

Please join me in congratulating 🎉 Malini, Susanne and Becky 🎉 on stepping into these very important roles! Their leadership will be instrumental in building a more connected and supportive HR experience for everyone.

What that means?

Who should you reach out to?

What’s next?

This is just the beginning. We’re also working on the implementation of a new HR Information System (BambooHR) that will streamline our processes, enhance collaboration, and help us stay better connected. More details will follow soon.

Looking ahead, we’ll continue developing HR processes tailored to our organization’s needs - creating a globally integrated and people-focused HR function for the entire Humaneva Group. We know… it sounds super easy 🙂 But we also know it takes collaboration, feedback, and great ideas to make it work.

Thank you for being part of this journey!

Best,

Mateusz

*Note: In case of Poland-based employees, please also feel free to contact AskHR (Neuca HR Team) for everyday or personal questions.

Becky Kowalczyk - previously responsible for HR in the United States, is now overseeing the entire Western Region. In this capacity, she acts as a regional HR Business Partner and leads the development of Learning & Development
Susanne Gensch - previously responsible for HR in Germany, is now overseeing the entire Central Region. In this capacity, she acts as a regional HR Business Partner and leads the development of Talent Acquisition
Malini Lakshman - previously responsible for HR in India, is now overseeing the entire Eastern Region. In this capacity, she acts as a regional HR Business Partner and leads the development of HR Operations